1e
19
1
49
2
2
18
1b
1d
18
31
75
1d
2 29
1d
25
Alan G. Wasserstein
78
75
Emeritus Associate Professor CE of Medicine (Renal-Electrolyte and Hypertension)
28
70
3
5f
Director, Quality Improvement, Renal Division, Univ of PA
64
Diversity Search Advisor, Penn Medical School
11
Department: Medicine
4
1
b
1d
46
Contact information
43
4
3
3
3
2
29
43
One Founders Pavilion
35 3400 Spruce Street
Philadelphia, PA 19104
26
35 3400 Spruce Street
Philadelphia, PA 19104
2c
Office: 2159007843
30 Fax: 2156150349
24
91
30 Fax: 2156150349
24
Email:
alanw@mail.med.upenn.edu
12
alanw@mail.med.upenn.edu
Links
df Penn's Renal-Electrolyte and Hypertension Division
be Penn Kidney Medicine Kidney Stone Clinic
ad Penn Kidney Medicine Dialysis Care
c
4
b
1f
df Penn's Renal-Electrolyte and Hypertension Division
be Penn Kidney Medicine Kidney Stone Clinic
ad Penn Kidney Medicine Dialysis Care
c
13
Education:
21 9 B.A. 25 (English, Summa Cum Laude) c
28 Amherst College, 1968.
21 9 M.D. c
3c Albert Einstein College of Medicine, 1973.
c
3
3
3
3
8a
Permanent link21 9 B.A. 25 (English, Summa Cum Laude) c
28 Amherst College, 1968.
21 9 M.D. c
3c Albert Einstein College of Medicine, 1973.
c
2 29
21
1e
1d
24
5e
65
f dialysis
62
e 29
27
Description of Research Expertise
27 Medical professionalism65
Description of Clinical Expertise
56 Nephrolithiasis, divalent cation metabolism and renal osteodystrophy,f dialysis
62
Description of Other Expertise
38 History and cultural studies of medicinee 29
23
10c Bilenker, JH, Demers, R, Porter, DL, Wasserstein, AG, Peters, E, Manaker, S.: Recombinant human erythropoietin usage in a large academic medical center. Am. J. Managed Care 8: 742-747, 2002.
b4 Rosas, SE, Wasserstein, A, Kobrin, S, Feldman, HI.: Preliminary observations of sildenafil treatment for erectile dysfunction in 68 dialysis patients. American Journal of Kidney Diseases 37(1): 134-137, Jan 2001.
ac Wasserstein, AG.: The more things change…[editorial] Am. J.Kidney Disease 38(2): 240-8, Aug 2001.
e7 Wasserstein, A: Nephrolithiasis. Primer on Kidney Diseases (National Kidney Foundation). A. Greenberg. San Diego (eds.). Academic Press, Page: 348-354, 2001.
e3 Wasserstein, AG.: Secondary Glomerulonephritidies. Immunologic Renal Diseases. Couser, WG (eds.). Lippincott, Williams and Wilkins, Page: 1247-1268, 2001.
be Sachdeo RC, Wasserstein AG, D'Souza J.: Oxcarbazepine (Trileptal)effect on serum sodium. Epilepsia. 40(7): 103, 1999.
75 Wasserstein, A.: Nephrolithiasis: Acute management and prevention. 3b Disease-a-Month 44: 196-213, 1998.
1c3 Mangram, AJ, Archibald, LK, Hupert, M, Tokars, J, Brennan, PJ, Arduino, M, Peterson, S, Park, S, Raymond, A, McCullough, M, Jones, M, Wasserstein, A, Kobrin, S, Jarvis, W.: Nationwide outbreak of sterile peritonitis among continuous cycling peritoneal dialysis patients associated with intrinsically contaminated dialysis fluid. Infection Control and Hosp Epid 18(5): 27, 1997.
9a Wasserstein, A: Membranous glomerulonephritis. J Am Soc Nephrol 8: 664-674, 1997.
2c
7
1d
1f
Selected Publications
8a Wasserstein, A.: Core Curriculum in Nephrology: Nephrolithiasis. Am. J. Kidney Dis 27 45: 422-428, 2005.10c Bilenker, JH, Demers, R, Porter, DL, Wasserstein, AG, Peters, E, Manaker, S.: Recombinant human erythropoietin usage in a large academic medical center. Am. J. Managed Care 8: 742-747, 2002.
b4 Rosas, SE, Wasserstein, A, Kobrin, S, Feldman, HI.: Preliminary observations of sildenafil treatment for erectile dysfunction in 68 dialysis patients. American Journal of Kidney Diseases 37(1): 134-137, Jan 2001.
ac Wasserstein, AG.: The more things change…[editorial] Am. J.Kidney Disease 38(2): 240-8, Aug 2001.
e7 Wasserstein, A: Nephrolithiasis. Primer on Kidney Diseases (National Kidney Foundation). A. Greenberg. San Diego (eds.). Academic Press, Page: 348-354, 2001.
e3 Wasserstein, AG.: Secondary Glomerulonephritidies. Immunologic Renal Diseases. Couser, WG (eds.). Lippincott, Williams and Wilkins, Page: 1247-1268, 2001.
be Sachdeo RC, Wasserstein AG, D'Souza J.: Oxcarbazepine (Trileptal)effect on serum sodium. Epilepsia. 40(7): 103, 1999.
75 Wasserstein, A.: Nephrolithiasis: Acute management and prevention. 3b Disease-a-Month 44: 196-213, 1998.
1c3 Mangram, AJ, Archibald, LK, Hupert, M, Tokars, J, Brennan, PJ, Arduino, M, Peterson, S, Park, S, Raymond, A, McCullough, M, Jones, M, Wasserstein, A, Kobrin, S, Jarvis, W.: Nationwide outbreak of sterile peritonitis among continuous cycling peritoneal dialysis patients associated with intrinsically contaminated dialysis fluid. Infection Control and Hosp Epid 18(5): 27, 1997.
9a Wasserstein, A: Membranous glomerulonephritis. J Am Soc Nephrol 8: 664-674, 1997.
2c